Movement Alert｜Oscar Health, Inc. Intraday Decline 5.32% in Regular Trading, UBS Says Q3 Upside May Be Limited

Market Focus10-17

On October 17, Oscar Health, Inc. posted an Intraday Decline of 5.32% in Regular Trading, with shares at $31.71 and turnover of $118 million.

The move followed a recent analyst note indicating that third-quarter upside may be less certain because the company’s updated outlook already reflects favorable medical utilization trends ahead of its November 5 earnings report.

UBS recently raised its price target to $36 from $26 while keeping a Neutral rating, and lifted its EPS estimates for 2026 through 2028 to $2.00, $2.30 and $2.80. However, it also said additional program integrity checks on a large member group could pressure revenue if disenrollment is elevated, potentially limiting upside even as management believes the impact can be absorbed within current guidance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment